How Cabozantinib is Being Used in Practice for Patients With RCC

April 28, 2017
Daniel James George, MD

Daniel James George, MD, professor of Medicine, professor in Surgery, Duke University School of Medicine, discusses how cabozantinib (Cabometyx) is currently being used in practice for patients with renal cell carcinoma (RCC).